Recent Patents on CNS Drug Discovery (Discontinued)
Title:Editorial :
Volume: 9 Issue: 1
Author(s): Vincenzo Di Marzo
Affiliation:
Export Options
About this article
Cite this article as:
Marzo Di Vincenzo, Editorial :, Recent Patents on CNS Drug Discovery (Discontinued) 2014; 9 (1) . https://dx.doi.org/10.2174/157488980901140428100532
DOI https://dx.doi.org/10.2174/157488980901140428100532 |
Print ISSN 1574-8898 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3954 |
27
Related Articles
-
Oncolytic Viruses: Programmable Tumour Hunters
Current Gene Therapy Surface Modification of Nanocarriers for Cancer Therapy
Current Nanoscience Lactate in Solid Malignant Tumors: Potential Basis of a Metabolic Classification in Clinical Oncology
Current Medicinal Chemistry PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
Current Medicinal Chemistry Editorial
Current Radiopharmaceuticals Angiogenesis: A Target for Cancer Therapy
Current Pharmaceutical Design Active Tumor Targeting of Nanomaterials Using Folic Acid, Transferrin and Integrin Receptors
Current Drug Discovery Technologies Viral Vectors for Gene-Directed Enzyme Prodrug Therapy
Current Gene Therapy Synthesis and Evaluation of Heterocycles Based Chalcone Derivatives as Antiproliferative Agents
Anti-Cancer Agents in Medicinal Chemistry Targeted Therapy for Glioblastoma: Lessons Learned and Future Directions
Current Cancer Therapy Reviews Meet Our Editorial Board Member
Current Neuropharmacology Factors Affecting the Metabolite Productions in Endophytes: Biotechnological Approaches for Production of Metabolites
Current Medicinal Chemistry Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design Pharmacogenetics of Non-small Cell Lung Cancer (NSCLC): Time to "Work it Out"?
Current Pharmaceutical Design The Past, Current Studies and Future of Organometallic <sup>99m</sup>Tc(CO)3 Labeled Peptides and Proteins
Current Pharmaceutical Design DNA Methylation as a Target of Epigenetic Therapeutics in Cancer
Anti-Cancer Agents in Medicinal Chemistry Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
Current Protein & Peptide Science Therapeutic Targeting of Malignant Glioma
Anti-Cancer Agents in Medicinal Chemistry Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
Current Molecular Medicine Targeting Neuronal Nicotinic Receptors in Cancer: New Ligands and Potential Side-Effects
Recent Patents on Anti-Cancer Drug Discovery